Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD
Abstract
Ischemic cerebrovascular disease is an important cause of physical disability and dementia. Oligodendrocytes (OLGs), which differentiate from oligodendrocyte precursor cells (OPCs), are crucial for remyelination of the damaged brain and functional recovery. Breast carcinoma amplified sequence 1 (BCAS1) has recently been shown to be highly expressed in newly formed pre-myelinating oligodendrocytes (pre-mOLGs), while its expression level is reduced in mature OLGs. In this study, we analyzed BCAS1 expression by immunohistochemical analysis of human post-mortem brain tissue from six stroke patients (death within 2 months after stroke onset) and eight small vessel disease (SVD) patients. Control post-mortem brain tissue was from eight age-matched patients without any obvious central nervous system (CNS) pathology. The Olig2 expression in the area corresponding to the same section of the BCAS1-stained slice was analyzed to determine the total oligodendrocyte lineage. The percentage of differentiating OPCs in the oligodendrocyte lineage was calculated as the ratio of BCAS1+ to Olig2+ cells (BCAS1+/Olig2+). The stroke and SVD cases showed demyelination with decreased expression of myelin basic protein (MBP, a mature OLG marker). The stroke cases showed significantly increased numbers of early-stage BCAS1+ cells with an immature morphology and Olig2+ cells (pan-oligodendrocyte lineages) in the peri-infarct areas in both the cortex and white matter, but showed no increase in the number…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BCAS1+ oligodendrocytes in the cortex appear in two main phenotypes: resting cells with few or no immunopositive processes, prevailing in the healthy adult brain, and activated cells with pre-myelinating/myelinating morphology characterized by internode formation.
“BCAS1+ oligodendrocytes in the cortex appear in two main phenotypes: cells with few or no immunopositive processes, prevailing in the healthy adult brain (‘resting’ BCAS1+ oligodendrocytes; arrows in Fig. 1A) and cells with a pre-myelinating morphology with multiple branches and myelinating morphology, characterized by internode formation (‘activated’ BCAS1+ oligodendrocytes; arrowheads in Fig. 1A”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [38]
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · see citing works
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · see citing works
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · see citing works
Oligodendrocytes and Ischemic Brain Injury
Dewar, D., Underhill, S. M., & Goldberg, M. P. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000053472.41007.f9 · Cited by 335 · see citing works
Towards defining the neuropathological substrates of vascular dementia
Kalaria, R. N., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.019 · Cited by 291 · see citing works
Cell cycle dynamics of NG2 cells in the postnatal and ageing brain
Psachoulia, K., Jamen, F., Young, K. M., & Richardson, W. D. (2009) · Neuron Glia Biology · doi:10.1017/s1740925x09990354 · Cited by 257 · see citing works
Fard, M. K., van der Meer, F., Sánchez, P., Cantuti-Castelvetri, L., Mandad, S., Jäkel, S., Fornasiero, E. F., Schmitt, S., Ehrlich, M., Starost, L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7816 · Cited by 247 · see citing works
White matter lesions defined by diffusion tensor imaging in older adults
Back, S. A., Kroenke, C. D., Sherman, L. S., Lawrence, G., Gong, X., Taber, E. N., Sonnen, J. A., Larson, E. B., & Montine, T. J. (2011) · Annals of Neurology · doi:10.1002/ana.22484 · Cited by 109 · see citing works
Maki, T., Liang, A. C., Miyamoto, N., Lo, E. H., & Arai, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00275 · Cited by 99 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis
Bergner, C. G., van der Meer, F., Franz, J., Vakrakou, A., Würfel, T., Nessler, S., Schäfer, L., Nau-Gietz, C., Winkler, A., Lagumersindez-Denis, N., et al. (2025) · Brain · doi:10.1093/brain/awae293 · Cited by 16 · see citing works
“31,37,38 We have shown previously that BCAS1+ oligodendrocyte density is increased in rodent white matter during myelin regeneration after toxic demyelination.”
Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
Chen, J. Q. A., Wever, D. D., McNamara, N. B., Bourik, M., Smolders, J., Hamann, J., & Huitinga, I. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1522381 · Cited by 9 · see citing works
- Authors
- Jiang, G., Ayaki, T., Maki, T., Yasuda, K., Yoshii, D., Kaji, S., & Takahashi, R.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Ayaki, Takashi
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2023-08
- Volume
- 812
- Pages
- 137405
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W4384937289
- Cited by
- 11
- References
- 9
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 3
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Update notices
- erratum (2024-03-28)
- Open access
- closed
- Licence
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (19\u202FK16277)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- BCAS1, oligodendrocyte precursor cells, ischemic stroke, cerebral small vessel disease, remyelination, demyelination, Olig2, myelin basic protein, oligodendrocyte maturation, postmortem brain
- MeSH terms
- Oligodendrocyte Precursor Cells, Ischemic Stroke, Cell Differentiation, Humans, Myelin Sheath, Neoplasm Proteins, Oligodendroglia, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review